ISCA1P1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.702600E-01
Normal-vs-Stage2
7.988400E-01
Normal-vs-Stage3
6.289600E-01
Normal-vs-Stage4
3.817800E-01
Stage1-vs-Stage2
2.210000E-01
Stage1-vs-Stage3
8.321500E-02
Stage1-vs-Stage4
8.507000E-01
Stage2-vs-Stage3
2.050600E-01
Stage2-vs-Stage4
2.084200E-01
Stage3-vs-Stage4
1.461910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.206800E-01
Normal-vs-AfricanAmerican
8.868400E-01
Normal-vs-Asian
9.546800E-01
Caucasian-vs-AfricanAmerican
8.135600E-01
Caucasian-vs-Asian
5.663200E-01
AfricanAmerican-vs-Asian
8.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.024000E-01
Normal-vs-Female
6.325600E-01
Male-vs-Female
2.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.953200E-01
Normal-vs-Age(41-60Yrs)
4.538600E-01
Normal-vs-Age(61-80Yrs)
8.608800E-01
Normal-vs-Age(81-100Yrs)
8.878800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.408600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.515400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.739800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.065800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.337200E-01
Normal-vs-Daily Drinker
9.651000E-01
Normal-vs-Weekly Drinker
8.893000E-01
Normal-vs-Occasional Drinker
5.188400E-01
Normal-vs-Social Drinker
4.652800E-01
Non Drinker-vs-Daily Drinker
3.315600E-01
Non Drinker-vs-Weekly Drinker
2.174800E-01
Non Drinker-vs-Occasional Drinker
3.711700E-02
Non Drinker-vs-Social Drinker
4.289600E-02
Daily Drinker-vs-Weekly Drinker
6.933400E-01
Daily Drinker-vs-Occasional Drinker
1.166810E-01
Daily Drinker-vs-Social Drinker
1.011630E-01
Weekly Drinker-vs-Occasional Drinker
2.594000E-01
Weekly Drinker-vs-Social Drinker
1.721230E-01
Occasional Drinker-vs-Social Drinker
7.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.650800E-01
Normal-vs-Grade 2
3.547000E-01
Normal-vs-Grade 3
7.920800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.995600E-01
Grade 1-vs-Grade 3
6.138400E-01
Grade 1-vs-Grade 4
5.650800E-01
Grade 2-vs-Grade 3
3.565200E-01
Grade 2-vs-Grade 4
3.547000E-01
Grade 3-vs-Grade 4
7.920800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.597000E-01
Normal-vs-NonDiabetic
7.792000E-01
Diabetic-vs-NonDiabetic
5.961400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.347200E-01
Normal-vs-NoPancreatitis
7.173800E-01
Pancreatitis-vs-NoPancreatitis
1.325960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.754800E-01
Normal-vs-N1
7.479200E-01
N0-vs-N1
4.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.706200E-01
Normal-vs-TP53-NonMutant
5.981000E-01
TP53-Mutant-vs-TP53-NonMutant
1.181190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
